SummitTX Capital’s Alkermes ALKS Stock Holding History

SummitTX Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.03M	Sell	134,194 -22,065	-14%	-$862K	0.18%	140
2026 Q1	$5.53M	Buy	+156,259	New	+$4.85M	0.17%	144

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SummitTX Capital's ALKS Position: Q2 2026 in Review

SummitTX Capital reduced its Alkermes (ALKS) stake by 14% in Q2 2026, selling an estimated $862K and leaving 134,194 shares worth $7.03M. The position accounts for 0.18% of the portfolio, ranked #140.

SummitTX Capital first reported a position in ALKS in Q1 2026 and has held it in 2 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

SummitTX Capital held 134,194 shares of Alkermes worth $7.03M as of Q2 2026.
SummitTX Capital sold 22,065 Alkermes shares in Q2 2026, an estimated $862K.
Alkermes made up 0.18% of SummitTX Capital's portfolio in Q2 2026, its #140 holding.
SummitTX Capital first reported a position in Alkermes in Q1 2026 and has held it in 2 quarters since.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.